Welcome to Next Generation Gene Therapy Vectors

Virtually uniting leading vector engineering, design, innovation, and R&D experts, Next Generation Gene Therapy Vectors is the only meeting dedicated to tackling the current limitations of gene therapy vectors including immunogenicity, toxicity and safety.

Hear from innovative biotechs and pioneering academic groups across 3 days of in-depth online case studies, interactive panel discussions, live Q&As, and virtual networking opportunities to meet and learn from those developing the next generation of gene therapy vectors to progress to the clinic.

Join the community online to:

24553

Identify potential vectors from early on in research that are not only safe and work in humans, but can be feasibly manufactured, saving time and money long-term, with insights from Takeda

 

24553

Discover how Dyno Therapeutics are leveraging artificial intelligence to improve specificity of gene delivery in vivo

24553

Understand how Generation Bio are pursuing lipid nanoparticle technology to reduce immunogenicity concerns and increase likelihood of redosing

 

24553

Investigate how promoter and transgene design are being optimized to improve vector efficiency and ultimately lower the dose required, with insights from LogicBio & Gyroscope

 

24553

Engineer vectors to transfect traditionally challenging targets, with insights from 4D Molecular Therapeutics